Phase III Trial_Providing professional financial news and data related to Phase III Trial, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

CSPC PHARMA (01093.HK): HB1801 Phase III Trial Starts in China

Tags：

CSPC PHARMA 01093.HK Phase III Trial

2026-09-24

Research
HK Stock Connect Daily Report: DMALL Leads with a 15.62% Gain，AI Retail Agent Ecosystem Accelerates - 20260924
Finance
TIMES ELECTRIC (03898.HK): INED Lin Zhaofeng resigns, successor at EGM
Finance
HSBC HOLDINGS (00005.HK): Grants 7.87m share options at GBP 12.17
Research
Hong Kong AI Concept Stock Daily: HORIZONROBOT-W Rises 2.22% as TSMC Raises Wafer Pricing - 20260924
Finance
MEDTIDE (03880.HK): Buys Hangzhou Site for Peptide CDMO Base
Finance
NewTimeSpace | Hong Kong Market Close: The Three Major Indices Opened Lower and Moved in a Choppy Range, with the Hang Seng Index Closing Down 0.29%
Finance
RISECOMM GP (01679.HK): Appoints Lin Yueping as Independent NED
Finance
CSPC PHARMA (01093.HK): HB1801 Phase III Trial Starts in China
Research
HK shares ETFs Daily Report: Ping An of China CSI HK Dividend ETF Leads with a 1.04% Gain as ChiNext and Biotech Pull Back Sharply — September 24, 2026
Research
Hong Kong Recently Listed Stocks Daily Report: DMALL Leads with 15.62% Gain, Tech Stocks Advance Broadly, Pharma Sector Under Relative Pressure - 20260924

Scan QR Code

Download App